Pharma giant's pullback from gene therapy puts spotlight on North Carolina operations
One of the largest pharmaceutical companies in North Carolina is discontinuing a gene therapy produced in the state.
More from North Carolina Business
Business North Carolina Magazine
Systel founder Keith Allison steps into chairman role as daughters lead company
North Carolina Business
•
Nov 10, 2025
Business North Carolina Magazine
Krispy Kreme posts $19M loss as restructuring follows McDonald's breakup
North Carolina Business
•
Nov 10, 2025
Business North Carolina Magazine
Gov. Stein touts N.C.'s biotech, EV strength after Asia trade trip
North Carolina Business
•
Nov 10, 2025
Business North Carolina Magazine
FEMA sends $155M for Helene recovery, projects in western N.C.
North Carolina Business
•
Nov 10, 2025
Business North Carolina Magazine
New N.C. program helps small businesses offer health insurance
North Carolina Business
•
Nov 7, 2025
Business North Carolina Magazine
Trump-backed $80B Westinghouse plan could lead to U.S. stake, IPO
North Carolina Business
•
Nov 7, 2025
Business North Carolina Magazine
Nvidia CEO predicts China will surpass U.S. in AI race
North Carolina Business
•
Nov 6, 2025
Business North Carolina Magazine
N.C. insurers propose 68% hike in dwelling policy rates
North Carolina Business
•
Nov 6, 2025